Shinshu University

The Faculty of Pharmaceutical Sciences and Shinshu University have collaborated to develop non-viral gene-edited CAR T cell therapy. Their partnership aims to revolutionize the field by enhancing the efficacy, safety, and accessibility of CAR T cell therapy. By combining their knowledge and expertise, they have overcome challenges in non-viral gene editing techniques, resulting in advancements that could improve precision, affordability, and scalability. Their work holds the potential to transform CAR T cell therapy, making it more effective, safe, and available to a broader patient population.